Loading…
Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia
Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature a...
Saved in:
Published in: | International journal of clinical pharmacy 2024-12, Vol.46 (6), p.1410-1418 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353 |
container_end_page | 1418 |
container_issue | 6 |
container_start_page | 1410 |
container_title | International journal of clinical pharmacy |
container_volume | 46 |
creator | AlAmri, Lamaa S. Alluwaymi, Wafa S. Alghamdi, Badr G. Alghanim, Rashed A. Almordi, Afnan S. Hettah, Reham F. Almushaikah, Sahar F. AlShahrani, Asma M. Alshammri, Nouf T. Aldossari, Salma M. AlAwn, Leena I. Alsaleh, Nada A. AlShehri, Ghadah H. |
description | Background
Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use.
Aim
To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA).
Method
A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs.
Results
A total of 1,165 MEs were reported. The majority of reported errors involved patients aged > 18 years old, with 72.2% (
n
= 841) being male. The central region was found to report errors more frequently (32.3%,
n
= 376). Pharmacists were reported to detect errors most frequently (59.6%,
n
= 695). MEs most often occurred in the prescribing stage (77.8%,
n
= 906), with “missing prescription information” (30.1%,
n
= 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%,
n
= 351). The majority of errors did not reach the patients (92.3%,
n
= 1,075), and those that did reach patients rarely resulted in harm (0.3%,
n
= 2).
Conclusion
This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors. |
doi_str_mv | 10.1007/s11096-024-01782-2 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11576782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A816837873</galeid><sourcerecordid>A816837873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</originalsourceid><addsrcrecordid>eNp9UsFu1DAQjRCIVqU_wAFF4sIlxWM7ccIFrVZAkVr1AJytiTPZdZW1FzuptPwAv43TLdsWodoH22_ee9aMXpa9BnYGjKn3EYA1VcG4LBiomhf8WXbMObBCKYDnhzsTR9lpjNcsLVlxKOXL7Eg0UAqQ4jj7vVxjQDNSsHG0JuboutzgFCnmvs8DbX0YKUGD_4Vb66gINOCMbKizBkfrXU4h-BA_JC0Ou2hvleOa8kvrkmvYze9zwmFc5x2O2GKk3Lr8G06dzRcBW4uvshc9DpFO786T7MfnT9-X58XF1Zevy8VFYSQXYwE1StUa0zcEAkm0VU2l6HjD-j7hZdupjneihLqsDRjgLclKtqolk-qiFCfZx73vdmpTB4bcGHDQ22A3GHbao9WPK86u9crfaIBSVWnOyeHdnUPwPyeKo97YaGgY0JGfohaskUzKRs2fvf2Heu2nkIaUWCBYKWsJzT1rhQNp63qfPjazqV7UUNVC1Uok1tl_WGl3tLHGO-ptwh8J-F5ggo8xUH9oEpieI6T3EdIpQvo2Qnpu7s3D8RwkfwOTCGJPiKnkVhTuW3rC9g9Rb9LX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130548419</pqid></control><display><type>article</type><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><source>Springer Nature</source><creator>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</creator><creatorcontrib>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</creatorcontrib><description>Background
Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use.
Aim
To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA).
Method
A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs.
Results
A total of 1,165 MEs were reported. The majority of reported errors involved patients aged > 18 years old, with 72.2% (
n
= 841) being male. The central region was found to report errors more frequently (32.3%,
n
= 376). Pharmacists were reported to detect errors most frequently (59.6%,
n
= 695). MEs most often occurred in the prescribing stage (77.8%,
n
= 906), with “missing prescription information” (30.1%,
n
= 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%,
n
= 351). The majority of errors did not reach the patients (92.3%,
n
= 1,075), and those that did reach patients rarely resulted in harm (0.3%,
n
= 2).
Conclusion
This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</description><identifier>ISSN: 2210-7703</identifier><identifier>ISSN: 2210-7711</identifier><identifier>EISSN: 2210-7711</identifier><identifier>DOI: 10.1007/s11096-024-01782-2</identifier><identifier>PMID: 39153143</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Clozapine ; Internal Medicine ; Medical errors ; Medication errors ; Medicine ; Medicine & Public Health ; Mental disorders ; Online databases ; Online health care information services ; Patients ; Pharmacy ; Primary care ; Research Article ; Schizophrenia</subject><ispartof>International journal of clinical pharmacy, 2024-12, Vol.46 (6), p.1410-1418</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 Springer</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</cites><orcidid>0000-0001-7807-4470</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39153143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlAmri, Lamaa S.</creatorcontrib><creatorcontrib>Alluwaymi, Wafa S.</creatorcontrib><creatorcontrib>Alghamdi, Badr G.</creatorcontrib><creatorcontrib>Alghanim, Rashed A.</creatorcontrib><creatorcontrib>Almordi, Afnan S.</creatorcontrib><creatorcontrib>Hettah, Reham F.</creatorcontrib><creatorcontrib>Almushaikah, Sahar F.</creatorcontrib><creatorcontrib>AlShahrani, Asma M.</creatorcontrib><creatorcontrib>Alshammri, Nouf T.</creatorcontrib><creatorcontrib>Aldossari, Salma M.</creatorcontrib><creatorcontrib>AlAwn, Leena I.</creatorcontrib><creatorcontrib>Alsaleh, Nada A.</creatorcontrib><creatorcontrib>AlShehri, Ghadah H.</creatorcontrib><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><title>International journal of clinical pharmacy</title><addtitle>Int J Clin Pharm</addtitle><addtitle>Int J Clin Pharm</addtitle><description>Background
Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use.
Aim
To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA).
Method
A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs.
Results
A total of 1,165 MEs were reported. The majority of reported errors involved patients aged > 18 years old, with 72.2% (
n
= 841) being male. The central region was found to report errors more frequently (32.3%,
n
= 376). Pharmacists were reported to detect errors most frequently (59.6%,
n
= 695). MEs most often occurred in the prescribing stage (77.8%,
n
= 906), with “missing prescription information” (30.1%,
n
= 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%,
n
= 351). The majority of errors did not reach the patients (92.3%,
n
= 1,075), and those that did reach patients rarely resulted in harm (0.3%,
n
= 2).
Conclusion
This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</description><subject>Clozapine</subject><subject>Internal Medicine</subject><subject>Medical errors</subject><subject>Medication errors</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental disorders</subject><subject>Online databases</subject><subject>Online health care information services</subject><subject>Patients</subject><subject>Pharmacy</subject><subject>Primary care</subject><subject>Research Article</subject><subject>Schizophrenia</subject><issn>2210-7703</issn><issn>2210-7711</issn><issn>2210-7711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UsFu1DAQjRCIVqU_wAFF4sIlxWM7ccIFrVZAkVr1AJytiTPZdZW1FzuptPwAv43TLdsWodoH22_ee9aMXpa9BnYGjKn3EYA1VcG4LBiomhf8WXbMObBCKYDnhzsTR9lpjNcsLVlxKOXL7Eg0UAqQ4jj7vVxjQDNSsHG0JuboutzgFCnmvs8DbX0YKUGD_4Vb66gINOCMbKizBkfrXU4h-BA_JC0Ou2hvleOa8kvrkmvYze9zwmFc5x2O2GKk3Lr8G06dzRcBW4uvshc9DpFO786T7MfnT9-X58XF1Zevy8VFYSQXYwE1StUa0zcEAkm0VU2l6HjD-j7hZdupjneihLqsDRjgLclKtqolk-qiFCfZx73vdmpTB4bcGHDQ22A3GHbao9WPK86u9crfaIBSVWnOyeHdnUPwPyeKo97YaGgY0JGfohaskUzKRs2fvf2Heu2nkIaUWCBYKWsJzT1rhQNp63qfPjazqV7UUNVC1Uok1tl_WGl3tLHGO-ptwh8J-F5ggo8xUH9oEpieI6T3EdIpQvo2Qnpu7s3D8RwkfwOTCGJPiKnkVhTuW3rC9g9Rb9LX</recordid><startdate>20241201</startdate><enddate>20241201</enddate><creator>AlAmri, Lamaa S.</creator><creator>Alluwaymi, Wafa S.</creator><creator>Alghamdi, Badr G.</creator><creator>Alghanim, Rashed A.</creator><creator>Almordi, Afnan S.</creator><creator>Hettah, Reham F.</creator><creator>Almushaikah, Sahar F.</creator><creator>AlShahrani, Asma M.</creator><creator>Alshammri, Nouf T.</creator><creator>Aldossari, Salma M.</creator><creator>AlAwn, Leena I.</creator><creator>Alsaleh, Nada A.</creator><creator>AlShehri, Ghadah H.</creator><general>Springer International Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7807-4470</orcidid></search><sort><creationdate>20241201</creationdate><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><author>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clozapine</topic><topic>Internal Medicine</topic><topic>Medical errors</topic><topic>Medication errors</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental disorders</topic><topic>Online databases</topic><topic>Online health care information services</topic><topic>Patients</topic><topic>Pharmacy</topic><topic>Primary care</topic><topic>Research Article</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlAmri, Lamaa S.</creatorcontrib><creatorcontrib>Alluwaymi, Wafa S.</creatorcontrib><creatorcontrib>Alghamdi, Badr G.</creatorcontrib><creatorcontrib>Alghanim, Rashed A.</creatorcontrib><creatorcontrib>Almordi, Afnan S.</creatorcontrib><creatorcontrib>Hettah, Reham F.</creatorcontrib><creatorcontrib>Almushaikah, Sahar F.</creatorcontrib><creatorcontrib>AlShahrani, Asma M.</creatorcontrib><creatorcontrib>Alshammri, Nouf T.</creatorcontrib><creatorcontrib>Aldossari, Salma M.</creatorcontrib><creatorcontrib>AlAwn, Leena I.</creatorcontrib><creatorcontrib>Alsaleh, Nada A.</creatorcontrib><creatorcontrib>AlShehri, Ghadah H.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlAmri, Lamaa S.</au><au>Alluwaymi, Wafa S.</au><au>Alghamdi, Badr G.</au><au>Alghanim, Rashed A.</au><au>Almordi, Afnan S.</au><au>Hettah, Reham F.</au><au>Almushaikah, Sahar F.</au><au>AlShahrani, Asma M.</au><au>Alshammri, Nouf T.</au><au>Aldossari, Salma M.</au><au>AlAwn, Leena I.</au><au>Alsaleh, Nada A.</au><au>AlShehri, Ghadah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</atitle><jtitle>International journal of clinical pharmacy</jtitle><stitle>Int J Clin Pharm</stitle><addtitle>Int J Clin Pharm</addtitle><date>2024-12-01</date><risdate>2024</risdate><volume>46</volume><issue>6</issue><spage>1410</spage><epage>1418</epage><pages>1410-1418</pages><issn>2210-7703</issn><issn>2210-7711</issn><eissn>2210-7711</eissn><abstract>Background
Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use.
Aim
To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA).
Method
A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs.
Results
A total of 1,165 MEs were reported. The majority of reported errors involved patients aged > 18 years old, with 72.2% (
n
= 841) being male. The central region was found to report errors more frequently (32.3%,
n
= 376). Pharmacists were reported to detect errors most frequently (59.6%,
n
= 695). MEs most often occurred in the prescribing stage (77.8%,
n
= 906), with “missing prescription information” (30.1%,
n
= 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%,
n
= 351). The majority of errors did not reach the patients (92.3%,
n
= 1,075), and those that did reach patients rarely resulted in harm (0.3%,
n
= 2).
Conclusion
This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39153143</pmid><doi>10.1007/s11096-024-01782-2</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7807-4470</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2210-7703 |
ispartof | International journal of clinical pharmacy, 2024-12, Vol.46 (6), p.1410-1418 |
issn | 2210-7703 2210-7711 2210-7711 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11576782 |
source | Springer Nature |
subjects | Clozapine Internal Medicine Medical errors Medication errors Medicine Medicine & Public Health Mental disorders Online databases Online health care information services Patients Pharmacy Primary care Research Article Schizophrenia |
title | Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20causes%20of%20reported%20clozapine-related%20medication%20errors:%20analysis%20of%20the%20Ministry%20of%20Health%20database%20in%20Saudi%20Arabia&rft.jtitle=International%20journal%20of%20clinical%20pharmacy&rft.au=AlAmri,%20Lamaa%20S.&rft.date=2024-12-01&rft.volume=46&rft.issue=6&rft.spage=1410&rft.epage=1418&rft.pages=1410-1418&rft.issn=2210-7703&rft.eissn=2210-7711&rft_id=info:doi/10.1007/s11096-024-01782-2&rft_dat=%3Cgale_pubme%3EA816837873%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130548419&rft_id=info:pmid/39153143&rft_galeid=A816837873&rfr_iscdi=true |